Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by George Washington University
Sponsor:
Collaborator:
Information provided by (Responsible Party):
George Washington University
ClinicalTrials.gov Identifier:
NCT01206920
First received: September 21, 2010
Last updated: March 18, 2014
Last verified: March 2014

September 21, 2010
March 18, 2014
January 2011
November 2016   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01206920 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort
Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort

The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for outpatients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) in Washington, DC.

All major community and academic clinics treating HIV-infected persons in the District of Columbia (DC) will initially be included in the development of a city-wide "DC Cohort" of HIV-infected persons in care, with consideration to be given subsequently to the inclusion of large private physician practices. Socio-demographics, risk factors, treatments, diagnoses, labs and procedures documented in outpatient medical record systems will be included in the DC Cohort database. Routine reports will be generated every six months for sites comparing their participants' socio-demographics, clinical status, treatments, and outcomes to all other data in the DC Cohort database, and other comparisons specifically requested by sites. All sites will be provided analytic support in research areas of interest.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Study participants will include men, women and children receiving HIV/AIDS care at major publicly-funded, government and academic medical centers in the District of Columbia.

  • HIV
  • AIDS
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
10000
November 2016
November 2016   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient is receiving care for HIV at one or more of the twelve participating clinics in the DC Cohort.
  • Patient is either age 18 years or older, or seeks HIV care independently and is able to understand and sign informed consent.
  • Patient is a minor who is consented by a parent or legal guardian.

Exclusion Criteria:

  • Patient is unable or refuses to provide informed consent.
  • Minor children ages 12 through 17 who are unaware of their HIV status
Both
Not Provided
No
Contact: Amanda D Castel, MD, MPH 202-994-8325 acastel@gwu.edu
Contact: Lindsey P Happ, MPH 202-994-3340 lpowers@gwu.edu
United States
 
NCT01206920
071029, 3U01AI069503-03S2
No
George Washington University
George Washington University
National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator: Amanda D Castel, MD, MPH George Washington University
George Washington University
March 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP